Wikisage, the free encyclopedia of the second generation, is digital heritage
Ethosuximide: Difference between revisions
Jump to navigation
Jump to search
mNo edit summary |
No edit summary |
||
| Line 8: | Line 8: | ||
[https://bmjopen.bmj.com/content/6/12/e013530 Assessment of the effectiveness and safety of Ethosuximide in the Treatment of non-Diabetic Peripheral Neuropathic Pain: EDONOT—protocol of a randomised, parallel, controlled, double-blinded and multicentre clinical trial] | [https://bmjopen.bmj.com/content/6/12/e013530 Assessment of the effectiveness and safety of Ethosuximide in the Treatment of non-Diabetic Peripheral Neuropathic Pain: EDONOT—protocol of a randomised, parallel, controlled, double-blinded and multicentre clinical trial] | ||
[https://www.sopnia.com/boletines/CONSENSO%2020112.pdf CONSENSO CHILENO DE MANEJO DE FÁRMACOS ANTIEPILÉPTICOS EN ALGUNOS SÍNDROMES ELECTRO-CLÍNICOS Y OTRAS EPILEPSIAS EN NIÑOS Y ADOLESCENTES] | |||
<references/> | <references/> | ||
Revision as of 01:21, 11 August 2018
non applicable in focal onset impaired awareness seizure[1]
ATC
https://www.whocc.no/atc_ddd_index/?code=N03AD01
